Patents by Inventor Robert Pearson Shepherd

Robert Pearson Shepherd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20240173302
    Abstract: A pharmaceutical composition comprising at least one endothelin A receptor inhibitor or a pharmaceutically acceptable salt thereof and at least one chemokine receptor 2 (CCR2) inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 18, 2022
    Publication date: May 30, 2024
    Inventors: Robert Pearson Shepherd, Nina Webster
  • METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASE
    Publication number: 20240009191
    Abstract: A pharmaceutical formulation comprising at least one angiotensin type 1 receptor (AT1R) blocker and at least one CXC chemokine receptor 2 (CXCR2) pathway inhibitor.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 11, 2024
    Inventors: Robert Pearson Shepherd, Kevin Donald George Pfleger
  • TREATMENT FOR ACUTE RESPIRATORY DISTRESS SYNDROME
    Publication number: 20230165838
    Abstract: A method for the treatment or amelioration of Acute Respiratory Distress Syndrome (ARDS) comprising the steps of administering to a subject a therapeutically effective amount of at least one chemokine receptor 2 (CCR2) pathway inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 3, 2021
    Publication date: June 1, 2023
    Inventors: Nina Webster, Robert Pearson Shepherd